| Application no. and date | 13749329.2 (espacenet) (Federated) (European Patent Register), 20130219 | | Patent/reg. no. and date | DK/EP 2841092, 20231206 | | Publication date | 20150304 | | Priority no. and date | US 201261600545 P, 20120217, US 201261727627 P, 20121116 | | EP pub. no. and date |
EP 2841092 20150304 | | Effective date | | | Applicant/owner | Ansun Biopharma, Inc., 10045 Mesa Rim Road
San Diego, CA 92121, US | | Applicant ref. no. | | | Inventor | MOSS, Ron, 1931 Avenida Joaquin
Encinitas, California 92024, US, LI, Tiejun,
Princeton, NJ 08540, US | | Representative | | | Opponent | | | IPC Class | A61K 31/16 (2006.01) , A61K 38/47 (2006.01) , A61K 9/00 (2006.01) , A61P 11/00 (2006.01) , A61P 11/12 (2006.01) , A61P 31/14 (2006.01) , A61P 31/16 (2006.01) , A61P 43/00 (2006.01) | | Title | Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients | | Int. application no. | US2013026754 | | Int. publication no. | WO2013123521 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|